AltrixBio Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$11.6M
- Investors
-
9
AltrixBio General Information
Description
Developer of therapeutic drugs designed for controlled gastrointestinal targeting. The company's drugs treat patients with obesity by providing duodenal isolation similar to gastric bypass, restricting the absorption of fats and glucose through the mucosa in the bowels, helping to reduce glucose levels, enabling patients with an oral medication that replicates the metabolic success of bariatric surgery and is more financially feasible than surgery.
Contact Information
Website
www.altrixbio.comCorporate Office
- 325 Vassar Street
- Suite 2A
- Cambridge, MA 02139
- United States
Corporate Office
- 325 Vassar Street
- Suite 2A
- Cambridge, MA 02139
- United States
AltrixBio Timeline
AltrixBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A) | 16-Sep-2025 | $11.6M | Completed | Generating Revenue | ||
| 4. Early Stage VC | 01-Nov-2023 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 01-Jan-2022 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 04-Jun-2020 | $3.2M | $3.3M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 01-Nov-2019 | $100K | $100K | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AltrixBio Comparisons
Industry
Financing
Details
AltrixBio Competitors (4)
One of AltrixBio’s 4 competitors is Glyscend Therapeutics, a Venture Capital-Backed company based in Baltimore, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Glyscend Therapeutics | Venture Capital-Backed | Baltimore, MD | ||||
| Fractyl Health | Formerly VC-backed | Burlington, MA | ||||
| Morphic Medical | Private Equity-Backed | Boston, MA | ||||
| GI Windows | Venture Capital-Backed | Canton, MA |
AltrixBio Patents
AltrixBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230310314-A1 | Mucoadhesive compositions for directional delivery of active agents | Inactive | 28-Feb-2022 | ||
| WO-2023164706-A1 | Mucoadhesive compositions for directional delivery of active agents | Inactive | 28-Feb-2022 |
AltrixBio Signals
AltrixBio Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| StageNext Fund | Venture Capital | Minority | ||
| Service Provider Capital | Venture Capital | Minority | ||
| 100 Plus Capital | Impact Investing | Minority | ||
| Arizona Tech Investors | Angel Group | Minority | ||
| Flybridge (New York) | Venture Capital | Minority |
AltrixBio FAQs
-
When was AltrixBio founded?
AltrixBio was founded in 2019.
-
Where is AltrixBio headquartered?
AltrixBio is headquartered in Cambridge, MA.
-
What is the size of AltrixBio?
AltrixBio has 7 total employees.
-
What industry is AltrixBio in?
AltrixBio’s primary industry is Drug Discovery.
-
Is AltrixBio a private or public company?
AltrixBio is a Private company.
-
What is AltrixBio’s current revenue?
The current revenue for AltrixBio is .
-
How much funding has AltrixBio raised over time?
AltrixBio has raised $14.9M.
-
Who are AltrixBio’s investors?
StageNext Fund, Service Provider Capital, 100 Plus Capital, Arizona Tech Investors, and Flybridge (New York) are 5 of 9 investors who have invested in AltrixBio.
-
Who are AltrixBio’s competitors?
Glyscend Therapeutics, Fractyl Health, Morphic Medical, and GI Windows are competitors of AltrixBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process